General MedicationsORALStandard
APREPITANT
APREPITANT
Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview APREPITANT is listed in Drugs@FDA under application 211835 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength CAPSULE;ORAL - 80MG Sponsor TORRENT Submission history Latest submission status date: 2022-08-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview APREPITANT is listed in Drugs@FDA under application 211835 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient APREPITANT Form and strength CAPSULE;ORAL - 80MG Sponsor TORRENT Submission history Latest submission status date: 2022-08-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.